%0 Journal Article
%T Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study.
%A Tan AJ
%A Xia J
%A Glennon CM
%A Locascio JJ
%A Gabel CK
%A Nguyen ED
%A Chand S
%A Rrapi R
%A Dobry AS
%A Garza-Mayers AC
%A Ko LN
%A Shah R
%A St John J
%A Nigwekar SU
%A Kroshinsky D
%J J Am Acad Dermatol
%V 0
%N 0
%D 2024 Jul 5
%M 38972479
%F 15.487
%R 10.1016/j.jaad.2024.06.058
%X <B>BACKGROUND: </B>Calciphylaxis patients historically have experienced diagnostic challenges and high morbidity; however limited data is available examining these characteristics over time.<BR><B>OBJECTIVE: </B>The primary goals were to a) investigate factors associated with diagnostic delay of calciphylaxis and b) assess morbidity outcomes. The secondary goal was to provide updated mortality rates.<BR><B>METHODS: </B>A retrospective review of 302 adult patients diagnosed with calciphylaxis between January 1, 2006 and December 31, 2022 was conducted. Univariate and multivariate statistical analyses were performed.<BR><B>RESULTS: </B>Nonnephrogenic calciphylaxis (P = .0004) and involvement of the fingers (P = .0001) were significantly associated with an increased diagnostic delay, whereas involvement of the arms (P = .01) and genitalia (P = .022) resulted in fewer days to diagnosis. Almost all patients with genitalia, finger, or toe involvement had nephrogenic disease. The number of complications per patient decreased with time, especially for wound infections (P = .028), increase in lesion number (P = .012), and recurrent hospitalizations (P = .020). Updated 1-year mortality rates were 36.70% and 30.77% for nephrogenic and nonnephrogenic calciphylaxis, respectively.<BR><B>CONCLUSIONS: </B>Limitations include the retrospective nature and data from a single institution.<BR><B>CONCLUSIONS: </B>Diagnostic delay, particularly in nonnephrogenic calciphylaxis, and complications per patient decreased with time, highlighting the importance of continued awareness to expedite diagnosis. Mortality rates have continued to improve in recent years.